Pharmala Biotech Pink Sheet Forecast - Polynomial Regression
| PMBHFDelisted Stock | 0.25 0.00 0.00% |
Pharmala |
Pharmala Biotech Polynomial Regression Price Forecast For the 13th of December 2024
Given 90 days horizon, the Polynomial Regression forecasted value of Pharmala Biotech Holdings on the next trading day is expected to be 0.23 with a mean absolute deviation of 0.03, mean absolute percentage error of 0, and the sum of the absolute errors of 1.24.Please note that although there have been many attempts to predict Pharmala Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Pharmala Biotech's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Pharmala Biotech Pink Sheet Forecast Pattern
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Pharmala Biotech pink sheet data series using in forecasting. Note that when a statistical model is used to represent Pharmala Biotech pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 81.9423 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0275 |
| MAPE | Mean absolute percentage error | 0.1105 |
| SAE | Sum of the absolute errors | 1.2356 |
Predictive Modules for Pharmala Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pharmala Biotech Holdings. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Please note, it is not enough to conduct a financial or market analysis of a single entity such as Pharmala Biotech. Your research has to be compared to or analyzed against Pharmala Biotech's peers to derive any actionable benefits. When done correctly, Pharmala Biotech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Pharmala Biotech Holdings.Pharmala Biotech Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pharmala Biotech pink sheet to make a market-neutral strategy. Peer analysis of Pharmala Biotech could also be used in its relative valuation, which is a method of valuing Pharmala Biotech by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Pharmala Biotech Market Strength Events
Market strength indicators help investors to evaluate how Pharmala Biotech pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pharmala Biotech shares will generate the highest return on investment. By undertsting and applying Pharmala Biotech pink sheet market strength indicators, traders can identify Pharmala Biotech Holdings entry and exit signals to maximize returns.
Pharmala Biotech Risk Indicators
The analysis of Pharmala Biotech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Pharmala Biotech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting pharmala pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.56 | |||
| Semi Deviation | 6.16 | |||
| Standard Deviation | 14.89 | |||
| Variance | 221.85 | |||
| Downside Variance | 248.2 | |||
| Semi Variance | 37.89 | |||
| Expected Short fall | (25.35) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in Pharmala Pink Sheet
If you are still planning to invest in Pharmala Biotech Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pharmala Biotech's history and understand the potential risks before investing.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |